Insmed IncorporatedINSMNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank93
3Y CAGR+80.8%
5Y CAGR+26.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+80.8%/yr
vs -40.7%/yr prior
5Y CAGR
+26.6%/yr
Recent acceleration
Acceleration
+121.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 61.74 | +85.8% |
| 2024 | 33.23 | +99.9% |
| 2023 | 16.62 | +59.2% |
| 2022 | 10.44 | -33.3% |
| 2021 | 15.65 | -17.6% |
| 2020 | 18.98 | +34.3% |
| 2019 | 14.13 | -83.2% |
| 2018 | 84.36 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |